Clinical Trial Update: A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 study to assess the safety and potential efficacy of LX3305 in subjects with active rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• LX3305

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED